Interleukin 2 enhanced the cytotoxic potential of lymphocytes in two different syngeneic tumor models, thus prolonging subject survival, when lymphocytes were cultured with or injected simultaneously with IL-2 [5,6]. Here, IL2 is linked to neoplasm.